je.st
news
Gilead's India patent snag may spur low-cost Sovaldi copies
2015-01-20 22:41:19| Biotech - Topix.net
The Indian patent office's rejection of a key patent for Gilead Sciences' Hepatitis C treatment Sovaldi may pave the way for more low-cost copies in the country. The New Delhi patent office this week rejected one of the patents for Sovaldi on the grounds that it "lacks novelty" and lacks an inventive step.
Tags: india
copies
patent
spur
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||